Q. Is there any cure for psoriasis? A. There’s no cure for psoriasis yet, but there are many ways to get relief from the symptoms of this troublesome disease. Psoriasis is one of the most ...

Biologics, which appear to have a safer risk-to-benefit ratio compared to cyclosporine, have more or less supplanted this drug for psoriasis in most patients. Humira (adalimumab) is a commonly ...

Findings by Johnson & Johnson’s pharma unit show that psoriasis sufferers can use its Tremfya (guselkumab) when AbbVie's blockbuster Humira doesn’t work. J&J is one of several companies trying ...

SB5, an adalimumab biosimilar approved in the US, is showing to be safe and effective for patients with psoriasis in the long ...

Psoriasis: Adalimumab Biosimilars Comparable With Originator Biosimilars show comparable safety with Humira among new users with psoriasis in a multinational cohort study, but discontinuations ...

Adalimumab was the third TNF inhibitor to be approved for psoriasis, but has been gaining momentum in the market against etanercept, owing to superior efficacy data from clinical trials (Psoriasis ...

Humira has been a blockbuster worldwide for nearly two decades. The biologic has multiple indications, including rheumatoid arthritis, Crohn’s disease and psoriasis. The Foundation asserts that ...

with the latter two rivalling Humira in indications such as rheumatoid arthritis and psoriasis. Kavya Gopal, head of specialty at Sandoz UK, said: “Biosimilars offer the NHS the potential to ...

With approvals in rheumatoid arthritis, psoriasis, and Crohn's disease, Humira holds a wide range of indications, but biosimilar versions of the drug led to price erosion beginning in 2023 and ...